EUVIMEDEUVIMED entdecken
Crossref

Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis

Megumu Osaki, Toru Arai, Hiromitsu Sumikawa, Takayuki Takimoto, Naoko Takeuchi, Akihiro Tamiya, Kyoichi Okishio, Yoshikazu Inoue

Oncology · 2023 · 101 (5) · 303-312

DOI: 10.1159/000529204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, online erschienen am 23.01.2023. Verfasst von Megumu Osaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan, mgmosk92@hotmail.co.jp. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Lung Neoplasms, Pneumonia. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pleuroparenchymal fibroelastosis (PPFE) findings are associated with poor prognosis in interstitial lung disease (ILD). However, the effect of PPFE findings on the development of immune checkpoint inhibitor-related pneumonitis (ICI-pneumonitis), a life-threatening adverse event, in lung cancer patients with ILD has not been elucidated. We aimed to determine whether PPFE findings are a risk factor for ICI-pneumonitis in lung cancer patients with ILD.

Methods

We retrospectively examined 712 lung cancer patients, including 173 patients with background ILDs, who received ICI therapy in our institute between December 2015 and May 2021.

Background

ILDs were radiologically classified into three types: lone PPFE, other ILDs with PPFE, and other ILDs without PPFE. The cumulative ICI-pneumonitis incidence curves and median overall survival (mOS) were compared between the three radiological types, and risk factors for ICI-pneumonitis were evaluated.

Results

Of 173 eligible patients with ILD, 23 patients (13.3%) experienced ICI-pneumonitis. The Kaplan-Meier method and the log-rank test showed that lone PPFE patients had significantly lower incidence of ICI-pneumonitis (p = 0.024) and longer mOS (575 vs. 326 days; p = 0.0096) than other ILDs patients. ICI-pneumonitis (p = 0.35) and mOS (p = 0.29) were not significantly different between other ILDs with and without PPFE. A multivariate Cox proportional hazards regression analysis revealed that lone PPFE pattern was an independent predictive factor for ICI-pneumonitis (hazard ratio, 0.20; 95% confidence interval, 0.043–0.93; p = 0.040).

Conclusion

ICI therapy could be safer in lone PPFE patients than in other ILDs patients with lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialLung NeoplasmsPneumoniaHumansImmune Checkpoint InhibitorsRetrospective StudiesTomography, X-Ray ComputedLung

Stichwörter der Autor:innen

Immune checkpoint inhibitorInterstitial lung abnormalitiesInterstitial lung diseaseLung neoplasmsPleuroparenchymal fibroelastosis

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan, mgmosk92@hotmail.co.jp.
  • Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.
  • Department of Radiology, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.
  • Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.

Zitieren

APA

Osaki, M., Arai, T., Sumikawa, H., Takimoto, T., Takeuchi, N., Tamiya, A., Okishio, K., & Inoue, Y. (2023). Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis. Oncology, 101(5), 303-312. https://doi.org/10.1159/000529204

Vancouver

Osaki M, Arai T, Sumikawa H, Takimoto T, Takeuchi N, Tamiya A, et al. Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis. Oncology. 2023;101(5):303-312. doi:10.1159/000529204

BibTeX
@article{Osaki2023,
  author = {Osaki, Megumu and Arai, Toru and Sumikawa, Hiromitsu and Takimoto, Takayuki and Takeuchi, Naoko and Tamiya, Akihiro and Okishio, Kyoichi and Inoue, Yoshikazu},
  title = {Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis},
  journal = {Oncology},
  year = {2023},
  volume = {101},
  number = {5},
  pages = {303--312},
  doi = {10.1159/000529204}
}
Kostenlos starten →